Vanguard Global Advisers’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.21M Sell
38,516
-2,412
-6% -$443K ﹤0.01% 691
2026
Q1
$7.72M Buy
+40,928
New +$8.62M ﹤0.01% 661

Other funds holding THC

Vanguard Global Advisers's THC Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Tenet Healthcare (THC) stake by 5.9% in Q2 2026, selling an estimated $443K and leaving 38,516 shares worth $7.21M. The position accounts for ﹤0.01% of the portfolio, ranked #691.

Vanguard Global Advisers first reported a position in THC in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.72M in Q1 2026. 665 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Vanguard Global Advisers held 38,516 shares of Tenet Healthcare worth $7.21M as of Q2 2026.
  • Vanguard Global Advisers sold 2,412 Tenet Healthcare shares in Q2 2026, an estimated $443K.
  • Tenet Healthcare made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #691 holding.
  • Vanguard Global Advisers first reported a position in Tenet Healthcare in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Tenet Healthcare position peaked at $7.72M in Q1 2026.
  • 665 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.